The Blue Cross Blue Shield Association Technology Evaluation Center: how we evaluate radiology technologies.
Evidence-based technology assessment can help answer critical questions concerning the safety, effectiveness, and appropriate uses of medical technologies. This practice can be used to avoid the promotion of ineffective technologies and the premature diffusion of technologies that have not been demonstrated to improve patient-oriented health outcomes, both of which draw resources from effective and appropriate medical care. This article describes the process of such evaluation as undertaken by the Blue Cross Blue Shield Association Technology Evaluation Center. The key components of the assessment process are described, including the problem formulation and evaluation of study quality, as well as the process by which the available evidence is judged against the five Technology Evaluation Center criteria.
Ziegler
Kathleen M
KM
Blue Cross Blue Shield Association, Technology Evaluation Center, Chicago, Illinois 60601, USA. kathleen.ziegler@bcbsa.com
Flamm
Carole Redding
CR
Aronson
Naomi
N
D035843:Biomedical Research / Q000191:economics* / Q000295:instrumentation*; D001709:Biotechnology / Q000191:economics / Q000295:instrumentation; D054598:Blue Cross Blue Shield Insurance Plans / Q000458:organization & administration*; D019544:Equipment Failure Analysis / Q000379:methods; D019317:Evidence-Based Medicine; D007349:Insurance, Health, Reimbursement; D011871:Radiology / Q000191:economics / Q000295:instrumentation*; D013673:Technology Assessment, Biomedical / Q000379:methods / Q000458:organization & administration*; D014481:United States